Phase 2 Lyme Disease Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
Lyme Disease
ModernaTX, Inc.350 enrolled8 locationsNCT07561294
Recruiting
Phase 2
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
Lyme Disease
Tarsus Pharmaceuticals, Inc.700 enrolled19 locationsNCT07562087
Recruiting
Phase 1Phase 2
Human Immune Response to Ixodes Scapularis Tick Bites
Lyme DiseaseTick-Borne DiseasesTick Resistance
National Institute of Allergy and Infectious Diseases (NIAID)60 enrolled1 locationNCT05036707
Recruiting
Phase 1Phase 2
Ceftriaxone for Post-Treatment Lyme Disease
Post-treatment Lyme Disease Syndrome
Hackensack Meridian Health20 enrolled1 locationNCT06785402
Recruiting
Phase 1Phase 2
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic EncephalomyelitisChronic Fatigue SyndromePost-treatment Lyme Disease Syndrome+1 more
Icahn School of Medicine at Mount Sinai120 enrolled1 locationNCT06511050